Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-08-09

Clinical Trial Update: A Comparison of Exparel Local Anesthetic in Total Knee Arthroplasty (TKA) Patients [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluating Exparel local anesthetic in total knee arthroplasty has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: Holy Cross Hospital, Florida | Conditions: Osteoarthritis, Knee, Arthroplasty, Replacement, Knee | Phase 4 | Status: WITHDRAWN